U.S. Oil and Gas Stock News

NYSE:CWT
NYSE:CWTWater Utilities

California Water Service Group (CWT) Margin Drop Challenges Bullish Growth Narrative Heading Into Q1 2026

California Water Service Group (CWT) has opened Q1 2026 earnings season with investors looking back at a recent run that saw Q4 2025 revenue at US$220 million and basic EPS of US$0.19, alongside trailing 12 month revenue of about US$1.0 billion and EPS of US$2.15. Over the last few reported quarters, revenue has moved from US$204 million in Q1 2025 to US$311 million in Q3 2025 before landing at US$220 million in Q4, while basic EPS ranged from US$0.22 to just over US$1.02 across the same...
NasdaqGS:VISN
NasdaqGS:VISNCommunications

Vistance Networks (VISN) Trailing Profitability And One Off Loss Test Bullish Growth Narrative

Vistance Networks (VISN) opened 2026 with a mixed tape of numbers, as recent quarters show total revenue moving from US$1,112.2 million in Q1 2025 to US$1,388.1 million in Q2, then US$1,629.7 million in Q3, before a reported loss of US$2,198.4 million in Q4, while basic EPS shifted from US$1.26 to US$0.06, then US$0.40 and finally a loss of US$0.54. Over the trailing twelve months to Q1 2026, basic EPS prints include US$0.03, US$0.42, US$1.34 and US$1.16, reflecting the impact of both...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Myr Group (MYRG) Margin Expansion To 3.7% Tests Bullish Profitability Narrative

MYR Group (MYRG) has opened 2026 with Q1 revenue of US$1.0b and basic EPS of US$3.01, backed by trailing twelve month EPS of US$9.14 on revenue of US$3.8b and earnings growth reported at about 309.8% over the past year. Over recent quarters, the company has seen revenue move from US$833.6m in Q1 2025 to US$1.0b in Q1 2026, while quarterly basic EPS shifted from US$1.46 to US$3.01 over the same stretch. This sets up a results season in which a 3.7% net margin, along with forecast earnings and...
NasdaqGM:SGMT
NasdaqGM:SGMTBiotechs

A Look At Sagimet Biosciences (SGMT) Valuation After Acne Trial Plans And Equity Raise

Trending interest in Sagimet Biosciences (SGMT) centers on its recent acne pipeline update, with plans to file an IND for denifanstat and to move both denifanstat and TVB-3567 into later stage clinical trials. See our latest analysis for Sagimet Biosciences. Those acne trial plans and the recent follow on equity raise come after a sharp run in the shares, with a 30 day share price return of 53.68% and a 1 year total shareholder return of 104.33% from a latest share price of US$8.03. This...
NasdaqCM:NECB
NasdaqCM:NECBBanks

Northeast Community Bancorp (NECB) Net Interest Margin Above 5% Challenges Bearish Credit Narratives

Northeast Community Bancorp (NECB) has just posted another quarter of solid profitability, with Q4 2025 revenue at US$26.8 million and basic EPS at US$0.81, while trailing 12 month figures show revenue of US$104.9 million, net income of US$44.4 million and basic EPS of US$3.35. Over the last few quarters, revenue has ranged from US$24.4 million in Q4 2024 to US$27.5 million in Q3 2024 as quarterly EPS moved between US$0.78 and US$0.97. This sets up a story where investors are watching how a...
NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Plexus (PLXS) Margin Improvement Reinforces Bullish Narratives In Q2 2026 Earnings

Plexus (PLXS) has just posted its Q2 2026 numbers, with revenue of US$1.2b, basic EPS of US$1.86 and net income excluding extra items of US$49.8m setting the tone for the latest update. The company has seen quarterly revenue move from US$980.2m in Q2 2025 to US$1.2b in Q2 2026, while basic EPS has shifted from US$1.44 to US$1.86 over the same period. This gives you a clear view of how the top line and EPS trend across recent quarters feeds into the current release. With trailing twelve month...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Kymera Therapeutics (KYMR) Q1 2026 Deepening Losses Test Bullish Revenue Growth Narrative

Kymera Therapeutics Q1 2026 earnings snapshot Kymera Therapeutics (KYMR) has kicked off Q1 2026 with the market watching closely after recent quarters that paired modest revenue with sizeable losses, including Q4 2025 revenue of US$2.9 million and a basic EPS loss of US$0.97 on net income excluding extra items of a US$87 million loss. Over the past year, the company has seen quarterly revenue range from US$2.8 million to US$22.1 million, while basic EPS losses moved between US$0.82 and...
NYSE:CVS
NYSE:CVSHealthcare

Is It Too Late To Consider CVS Health (CVS) After Its Recent Share Price Rally?

If you are wondering whether CVS Health at around US$83.29 is a fair deal or starting to look expensive, the recent share performance gives you a lot to think about. The stock has returned 5.6% over the last 7 days, 16.0% over the past 30 days, 3.9% year to date, 24.3% over 1 year, 36.0% over 3 years and 17.4% over 5 years, which naturally raises questions about how much of this is already reflected in the price. Recent headlines around CVS Health have focused on its position as a large...
NYSE:CAT
NYSE:CATMachinery

Caterpillar (CAT) Margin Compression Challenges Bullish Earnings Growth Narrative In Q1 2026

Caterpillar Q1 2026 earnings set the stage for mixed margin signals Caterpillar (CAT) has just opened 2026 with Q1 results that sit against a trailing twelve month backdrop of US$67.6b in revenue and US$8.9b in net income, with full year 2025 Q4 revenue at US$19.1b and basic EPS of US$5.15 anchoring the latest reported quarter. Over recent quarters the company has seen revenue move from US$16.2b in Q4 2024 to US$19.1b in Q4 2025, while quarterly basic EPS has ranged from US$4.22 in Q1 2025 to...
NasdaqGS:BAND
NasdaqGS:BANDTelecom

Bandwidth (BAND) Losses Challenge Bullish Margin Narrative Heading Into Q1 2026

Bandwidth (BAND) has opened Q1 2026 earnings season with a recent run of quarterly revenue figures that sit in the low to mid US$100 million range and EPS still in loss making territory, with Q4 2025 revenue at US$207.7 million and basic EPS at a loss of US$0.10, compared with Q4 2024 revenue of US$210.0 million and a loss per share of US$0.06. Over the last year, the company has seen revenue move from US$748.5 million on a trailing basis at Q4 2024 to US$753.8 million at Q4 2025. Over the...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Is Qfin Holdings (QFIN) Offering Value After A 65% One Year Share Price Slump

If you are trying to work out whether Qfin Holdings at around US$13.08 is a bargain or a value trap, the recent share performance gives you a useful starting point. The stock has seen mixed returns, with a 2.6% gain over the last 7 days and 1.3% over the last 30 days, set against a 31.3% year to date decline and a 64.8% decline over the past year. Those moves sit within a longer track record where 3 year returns are 11.5% lower and 5 year returns are 28.4% lower. This can influence how the...
NYSE:CCL
NYSE:CCLHospitality

Is Carnival (CCL) Still Attractive After Its Strong Three Year Share Price Rebound

Wondering if Carnival Corporation & at around US$26.51 is offering real value or just headline excitement? This breakdown will help you connect the recent share price with what the business might be worth. The stock has delivered a 43.0% return over the last year and 183.6% over three years, even though the year-to-date return sits at a 14.3% decline and the last 7 days were roughly flat at a 0.5% fall. Recent attention on the cruise sector has focused on demand recovery, capacity deployment...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Is It Time To Reassess Henry Schein (HSIC) After Recent Share Price Volatility?

This article examines whether Henry Schein, trading at around US$74, is priced fairly or presents a potential mispricing opportunity by breaking down what the current share price might be implying. The stock is up 15.7% over the past year, while the year-to-date return is a 2.9% decline, with a 4.6% drop over the last week and a 1.2% gain over the past month. Recent coverage has focused on Henry Schein as a healthcare supplier navigating changes in demand across dental and medical markets,...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Crocs (CROX) Trailing 12 Month Loss Challenges Bullish Profitability Narratives Heading Into Q1 2026

Crocs (CROX) has just posted its Q1 2026 results against a backdrop of mixed recent performance, with Q4 2025 revenue at US$957.6 million and basic EPS of US$2.05, alongside trailing twelve month revenue of about US$4.0 billion and a basic EPS loss of US$1.50. Over the last few quarters, the company has seen revenue move from US$989.8 million and EPS of US$6.40 in Q4 2024 to US$937.3 million and EPS of US$2.85 in Q1 2025, then to US$1,149.4 million with a quarterly EPS loss of US$8.82 in Q2...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

Cimpress (CMPR) Tighter 0.7% Margin Tests Bullish Earnings Growth Narrative Before Q3 2026 Results

Cimpress (CMPR) has put fresh numbers on the table for Q3 2026, with recent quarterly revenue running between about US$789 million and US$1.0 billion, while Basic EPS across those periods ranged from a loss of US$1.02 to a profit of US$2.45 per share as net income swung between losses and profits. Over the past few quarters, the company has seen revenue move from US$789.5 million in Q3 2025 to US$1.04 billion in Q2 2026, with EPS shifting from a loss of US$0.33 per share to a gain of US$2.01...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA (KLAC) Margin Expansion To 35.7% TTM Reinforces Bullish Earnings Narratives

KLA (KLAC) has put another solid quarter on the table, with Q3 2026 revenue of US$3.4b, basic EPS of US$9.17 and trailing twelve month EPS of US$35.52 setting the tone for its latest results. The company has seen revenue move from US$3.1b in Q2 2025 to US$3.4b in Q3 2026, while quarterly EPS has ranged from US$6.18 to US$9.17 over that period. This gives a clear view of how the top line and per share earnings have tracked into this release as margins support the story. See our full analysis...
NYSE:SMG
NYSE:SMGChemicals

Scotts Miracle-Gro (SMG) Margin Rebound Challenges Longstanding Bearish Earnings Narrative

Scotts Miracle-Gro (SMG) just posted Q2 2026 results with revenue of US$1.5 billion and basic EPS of US$4.53, while trailing 12 month figures show revenue of US$3.5 billion and EPS of US$3.56. Over the past year, revenue has held around the US$3.4 billion to US$3.5 billion mark on a trailing basis, with EPS moving from US$0.69 in the Q2 2025 trailing window to US$3.56 most recently. This sets up this quarter as an important reference point for how earnings are tracking. With net profit...
NYSE:MCS
NYSE:MCSEntertainment

Marcus (MCS) Profitability Turnaround Reinforces Bullish Margin Narrative Heading Into Q1 2026

Marcus (MCS) opened Q1 2026 reporting season with context shaped by recent quarters that saw total revenue between US$178.1 million and US$222.3 million and basic EPS ranging from a loss of US$0.53 per share to a profit of US$0.73 per share. This sets the stage for how you judge the latest print against a swing back to profitability over the past year. Over the past six reported quarters, revenue has moved from US$178.1 million in Q4 2024 to US$183.7 million in Q4 2025, while basic EPS...
NYSE:SCI
NYSE:SCIConsumer Services

SCI (SCI) Q1 EPS Of US$0.98 Tests Bullish Earnings Growth Narrative

Service Corporation International (SCI) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$0.98. This sets the tone for how the business is translating its network and pricing into earnings at the current US$81.03 share price. Over recent quarters the company has reported revenue between US$1.06 billion and US$1.11 billion, while quarterly EPS has ranged from about US$0.84 to US$1.14, giving investors a consistent read on how volume, pricing, and mix are feeding through to the...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

C.H. Robinson (CHRW) Margin Improvement Reinforces Bullish Automation Narratives Ahead Of Q1 2026

C.H. Robinson Worldwide (CHRW) has put fresh numbers on the board for Q1 2026, with recent quarterly revenue sitting between US$3.9 billion and US$4.1 billion over 2025 and basic EPS ranging from about US$1.12 to US$1.36, alongside a 26.1% earnings lift over the past year. Over the last six reported quarters, revenue has moved from US$4,644.6 million in Q3 2024 to US$3,912.6 million in Q4 2025, while basic EPS has shifted from US$0.81 to US$1.14, setting the backdrop for that trailing 12...
NYSE:TWI
NYSE:TWIMachinery

Titan International (TWI) Deepening EPS Losses Challenge Bullish Margin Recovery Narratives

Titan International (TWI) has kicked off the Q1 2026 reporting cycle with a recent stretch of results that show revenue between US$383.6 million and US$490.7 million per quarter and basic EPS moving from a profit of US$0.02 in Q4 2024 to a loss of US$0.88 in Q4 2025. Over the past six reported quarters, the company has seen revenue range from US$383.6 million to US$490.7 million, while basic EPS shifted from US$0.02 to losses of up to US$0.88. This sets a clear backdrop for how margins have...
NasdaqCM:JMSB
NasdaqCM:JMSBBanks

John Marshall Bancorp (JMSB) Net Margin Strength Challenges Cautious Earnings Narratives

John Marshall Bancorp (JMSB) opened 2026 with Q1 total revenue of US$16.8 million and basic EPS of US$0.43, while trailing 12 month figures show revenue of US$63.3 million and EPS of US$1.58 backed by net income of US$22.4 million. Over recent quarters the company has seen total revenue move from US$14.4 million in Q1 2025 to US$15.7 million in Q4 2025 and EPS shift from US$0.34 to US$0.42. This feeds into trailing 12 month net income rising from US$17.1 million a year ago to US$22.4 million...
NYSE:TDAY
NYSE:TDAYMedia

USA Today (TDAY) Margins Stay Razor Thin As Profitability Narrative Faces New Test

USA TODAY (TDAY) opened Q1 2026 reporting Q4 2025 revenue of US$585.0 million and a basic EPS loss of US$0.21, with net income excluding extra items at a loss of US$30.1 million. The trailing twelve months to Q4 2025 showed total revenue of about US$2.3 billion and basic EPS of US$0.01. Over recent quarters the company has reported revenue between US$560.8 million and US$621.3 million, with EPS ranging from a profit of US$0.54 in Q2 2025 to several loss-making quarters. Investors are likely...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

Assessing CVB Financial (CVBF) Valuation After Recent Steady Share Price Performance

What recent performance says about CVB Financial (CVBF) CVB Financial (CVBF) has quietly put together steady returns, with the share price up about 0.6% over the past day, 0.8% over the past week, and 5.1% over the past month. Over the past 3 months, the stock has returned roughly 3.3%, contributing to a year to date gain of 9.1% and a 1 year total return of 13.2%, based on recent pricing around $20.37. See our latest analysis for CVB Financial. The recent 5.1% 1 month share price return...